Hikma Pharmaceuticals PLC (HKMPF) Q2 2025 Q&A Earnings Call Transcript

2025-08-08 09:06:52 ET

Hikma Pharmaceuticals PLC (HKMPF)

Q2 2025 Q&A Earnings Call

August 7, 2025 4:00 A.M. ET

Company Participants

Khalid Waleed Hosny Al Nabilsi - Chief Financial Officer

Riad Ali Mishlawi - CEO & Director

Conference Call Participants

Beatrice Rose Fairbairn - Joh. Berenberg, Gossler & Co. KG, Research Division

James Daniel Gordon - JPMorgan Chase & Co, Research Division

Kane Slutzkin - Deutsche Bank AG, Research Division

Sebastien Guillaume-Bernard Jantet - Panmure Liberum Limited, Research Division

Sidhartha Modi - Barclays Bank PLC, Research Division

Victor Floch - BNP Paribas Exane, Research Division

Xue Chen - Barclays Bank PLC, Research Division

Presentation

Operator

Welcome to Hikma's 2025 Interim Results meeting with our CEO, Riad Mishlawi; and CFO of Khalid Nabilsi.

Before we start, I'd like to remind you that any forward-looking statements or projections made by Hikma during this call are made in good faith based on information currently available and are subject to risks and uncertainties that may cause actual results to differ materially from those projected. For further information, please see the Principal Risks and Uncertainties section in Hikma's latest annual report....

Read the full article on Seeking Alpha

For further details see: